Improvement of skin sclerosis after occurrence of anticentromere antibody in a patient with diffuse cutaneous systemic sclerosis

被引:4
作者
Hayakawa, I [1 ]
Sato, S [1 ]
Echigo, T [1 ]
Shirasaki, F [1 ]
Hasegawa, M [1 ]
Takehara, K [1 ]
机构
[1] Kanazawa Univ, Grad Sch Med Sci, Dept Dermatol, Kanazawa, Ishikawa 9208641, Japan
关键词
anticentromere antibody; Pneumocystis carinii pneumonia; systemic sclerosis;
D O I
10.1007/s10067-004-0876-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 38-year-old woman had noticed sclerodactylia and Raynaud's phenomenon 10 months before consultation. She was diagnosed as having systemic sclerosis (SSc) based on the skin sclerosis of her arms, chest, and face. Antinuclear antibody (ANA) level was 1:1280 with a speckled pattern, but specific autoantibodies were negative. Following the treatment with oral prednisolone and D-penicillamine, her skin sclerosis gradually improved. Three months after initiation of prednisolone, she presented Pneumocystis carinii pneumonia. About 1 year after the first admission, the pattern of indirect immunofluorescence staining changed from the speckled pattern to the discrete speckled pattern, and simultaneously anticentromere antibody (ACA) was detected by enzyme-linked immunosorbent assay. Her skin sclerosis rapidly and remarkably improved after appearance of ACA. It is generally considered that once certain SSc-specific autoantibody occurs, it does not disappear and change into other specificity of autoantibody thereafter. This case suggests that the presence of ACA closely correlates with clinical features and also suggests that clinical features may change during the clinical course with the appearance of another specific ANA. This case is very rare because such a case was not reported previously.
引用
收藏
页码:345 / 347
页数:3
相关论文
共 12 条
[1]   PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH CONNECTIVE-TISSUE DISEASE [J].
CHECHANI, V ;
BRIDGES, A .
CHEST, 1992, 101 (02) :375-378
[2]   Role of infectious agents in the pathogenesis of systemic sclerosis [J].
Hamamdzic, D ;
Kasman, LM ;
LeRoy, EC .
CURRENT OPINION IN RHEUMATOLOGY, 2002, 14 (06) :694-698
[3]   CLINICAL-SIGNIFICANCE OF ANTINUCLEAR ANTIBODIES IN JAPANESE PATIENTS WITH SYSTEMIC-SCLEROSIS [J].
IGARASHI, A ;
TAKEHARA, K ;
SOMA, Y ;
KIKUCHI, K ;
ISHIBASHI, Y .
DERMATOLOGICA, 1990, 180 (03) :136-140
[4]  
LEROY EC, 1988, J RHEUMATOL, V15, P202
[5]  
Medsger T.A., 1996, Systemic Sclerosis, P51, DOI DOI 10.1002/ART.1780390421
[6]   D-PENICILLAMINE THERAPY IN PROGRESSIVE SYSTEMIC-SCLEROSIS (SCLERODERMA) - A RETROSPECTIVE ANALYSIS [J].
STEEN, VD ;
MEDSGER, TA ;
RODNAN, GP .
ANNALS OF INTERNAL MEDICINE, 1982, 97 (05) :652-659
[7]   CLINICAL CORRELATIONS AND PROGNOSIS BASED ON SERUM AUTOANTIBODIES IN PATIENTS WITH SYSTEMIC-SCLEROSIS [J].
STEEN, VD ;
POWELL, DL ;
MEDSGER, TA .
ARTHRITIS AND RHEUMATISM, 1988, 31 (02) :196-203
[8]   DIVERSITY OF ANTI-NUCLEAR ANTIBODIES IN PROGRESSIVE SYSTEMIC-SCLEROSIS - ANTI-CENTROMERE ANTIBODY AND ITS RELATIONSHIP TO CREST SYNDROME [J].
TAN, EM ;
RODNAN, GP ;
GARCIA, I ;
MOROI, Y ;
FRITZLER, MJ ;
PEEBLES, C .
ARTHRITIS AND RHEUMATISM, 1980, 23 (06) :617-625
[9]  
Ward MM, 1999, ARTHRITIS RHEUM, V42, P780, DOI 10.1002/1529-0131(199904)42:4&lt
[10]  
780::AID-ANR23&gt